Related references
Note: Only part of the references are listed.Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia
Huining Kang et al.
BLOOD (2010)
Molecular Genetics of Acute Lymphoblastic Leukemia
Michael A. Teitell et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2009)
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Lisa J. Russell et al.
BLOOD (2009)
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Charles G. Mullighan et al.
NATURE GENETICS (2009)
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia.
Charles G. Mullighan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
JAK mutations in high-risk childhood acute lymphoblastic leukemia
Charles G. Mullighan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz et al.
BLOOD (2008)
Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome
Dani Bercovich et al.
LANCET (2008)
Acute lymphoblastic leukaemia
Ching-Hon Pui et al.
LANCET (2008)
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan et al.
NATURE (2008)
Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Charles G. Mullighan et al.
SCIENCE (2008)
JAK2 inhibitor therapy in myeloproliferative disorders: rationale, preclinical studies and ongoing clinical trials
A. Pardanani
LEUKEMIA (2008)
Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Rα signaling
Valerie I. Brown et al.
CANCER RESEARCH (2007)
Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma
C. T. Storlazzi et al.
LEUKEMIA (2007)
Local increase in thymic stromal lymphopoietin induces systemic alterations in B cell development
Alexander Astrakhan et al.
NATURE IMMUNOLOGY (2007)
Outlier sums for differential gene expression analysis
Robert Tibshirani et al.
BIOSTATISTICS (2007)
COPA- cancer outlier profile analysis
James W. MacDonald et al.
BIOINFORMATICS (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia
CH Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins et al.
SCIENCE (2005)
Molecular genetics of acute lymphoblastic leukemia
SA Armstrong et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Pre-B cell receptor expression is necessary for thymic stromal lymphopoietin responsiveness in the bone marrow but not in the liver environment
CAJ Vosshenrich et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
ME Ross et al.
BLOOD (2003)
Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation
H Quentmeier et al.
LEUKEMIA (2001)
Molecular cloning of a human novel type I cytokine receptor related to delta 1/TSLPR
Y Tonozuka et al.
CYTOGENETICS AND CELL GENETICS (2001)
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor
LS Park et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin
A Pandey et al.
NATURE IMMUNOLOGY (2000)
Share Paper
